Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy

BACKGROUD: Recent trials suggest sodium-glucose cotransporter 2 inhibitors (SGLT2i) significantly reduced proteinuria in patients with IgA nephropathy (IgAN). While little was known its efficacy in clinical practice especially in those already received full dose reninangiotensin-aldosterone system (...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yaping, Shi, Sufang, Liu, Lijun, Zhou, Xujie, Lv, Jicheng, Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509766/
https://www.ncbi.nlm.nih.gov/pubmed/37736600
http://dx.doi.org/10.3389/fmed.2023.1242241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509766/
https://www.ncbi.nlm.nih.gov/pubmed/37736600
http://dx.doi.org/10.3389/fmed.2023.1242241

Ejemplares similares